PharmRep Direct from the editors of Pharmaceutical Representative Visit www.PharmRep.com Today!

January 7th , 2010 Issue 39 Vol. 1
www.pharmrep.com  
Contact Editor: Reid Paul
PharmRep Direct News

Novartis starts 2010 with a Bang
It’s just a few days into the new year and already a potential megamerger has been announced: Novartis offered $39 billion for complete control of ocular drug manufacturer Alcon
» MORE

Antidepressants Might Not Be A Sure Shot
A new JAMA study reveals that antidepressants might not have as strong an effect on people with less severe cases of depression. How this will affect the pharma industry, which once made heaps of cash with drugs like Prozac, remains to be seen
» MORE

Pharma Unplugged Episode #3:
George Koroneos, Pharm Exec news editor, and Pharm Rep Editor-in-Chief Reid Paul cover the top five trends and news stories in the pharmaceutical industry for 2009
» MORE

PharmRep Direct Features

Change Agent
FDA Commissioner Margaret Hamburg has a history of health advocacy and a clear mandate to transform the agency. But can she succeed where others have failed?
» MORE

Drug Topics' 2010 Pharmacy Business Outlook survey
Gloom may pervade much of the economy, but the pharmacy business is strong, and despite some challenges, will remain so
» MORE

2010 Forecast: Key Products and Leading Therapeutic Classes
Alexandra Kibble of Thomson Reuters identifies the products and therapy areas to watch next year
» MORE


 
FindPharma   Search
 
Subscribe To PharmRep Today!
PharmRep Direct Survey, Vote Today!
The more people talk about healthcare reform the less consensus there is, what do you think of current efforts to reform the system?
Click Here to Vote

PharmRep Direct Quick Links
Spooning Up the Wrong Dose

Healthcare Market Shows Job Growth

FDA Funds Study on Drugs During Pregnancy


Follow Pharm Rep on Twitter



You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit PharmRep.com Today! Visit www.PharmRep.com Today!